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Abstract.  
The MRC funded Virtual Organisations for Trials and Epidemiological Studies (VOTES) 
project is a collaborative effort between e-Science, clinical and ethical research centres 
across the UK including the universities of Oxford, Glasgow, Imperial, Nottingham and 
Leicester. The project started in September 2005 and is due to run for 3 years. The 
primary goal of VOTES is to develop a reusable Grid framework through which a 
multitude of clinical trials and epidemiological studies can be supported. The National e-
Science Centre (NeSC) at the University of Glasgow are looking at developing the 
Scottish components of this framework. This paper presents the initial experiences in 
developing this framework and in accessing and using existing data sets, services and 
software across the NHS in Scotland. 
 
1. Introduction 
Reliable assessment of moderate effects of treatment of important diseases (such as cardiovascular 
disease and cancer) on major clinical outcomes requires studies that guarantee both strict control of 
bias (which, in general, requires proper randomization and appropriate analysis) and strict control of 
random error (which, in general, requires large numbers of relevant outcomes). Generating this 
evidence typically requires the collection of data on many thousands of people over a period of at least 
several years.  Similarly, observational studies assessing the impact of particular exposures (such as 
cigarette smoking, industrial chemicals or blood cholesterol) to important clinical outcomes can require 
large numbers of such events during prolonged follow-up, in order to avoid misleading results caused 
by the play of chance.  The conduct of large-scale randomized trials or observational studies usually 
requires a collaborative effort, in which data are collected from individuals and from existing health 
records at multiple investigative sites, and study progress, data quality and analysis of results are 
managed by one or more coordinating centres. 
Grid technology provides one way in which remote, heterogeneous clinical data sets that are often 
managed by numerous independent bodies, can be seamlessly brought together. A Grid can be defined 
as a software infrastructure (including computer systems and data storage resources) that enables 
flexible, secure, co-ordinated resource sharing among dynamic collections of individuals, institutions 
and resources.  For clinical trials and observational studies, the particular attractions of a Grid-based 
approach are the ability to create, and subsequently manage, virtual organisations (VOs). VOs provide 
frameworks through which the rules associated with the participants and resources are agreed and 
enforced.  This may well involve agreements upon the remote resources themselves (databases and 
repositories, as well as the data sets contained therein) and the services that they agree to make 
available to one another.  The domain of large-scale clinical studies provides special challenges in the 
level of granularity associated with the rules, agreements and policies that might be present in a given 
clinical virtual organisation (CVO).  In particular, CVO policies must strongly adhere to local policy 
constraints, for example, on data sharing or confidentiality. 
It is expected that improved procedures for patient identification and recruitment, data collection 
and study management can be achieved by the development of Grid infrastructure to create such CVOs.  
For example, subject to strict ethical, data protection and security constraints, information can be 
shared between databases established for routine clinical use (such as general practice and hospital 
records, disease-specific registries, and central registries) and databases established especially for a 
particular trial or observational study.  Appropriate access to information from routine clinical systems 
should enable more efficient recruitment and more complete follow-up of participants in large-scale 
clinical studies to be achieved more economically. Furthermore, combining up-to-date data on study 
participants from both routine and research systems, will allow organisers of clinical trials and 
observational studies to conduct effective and efficient monitoring of these studies, so that potential 
problems are identified early.  This will be particularly valuable in helping organizations comply with 
their responsibilities for monitoring under the EU Clinical Trials Directive (2001/20/EC). In addition, 
the use of a Grid infrastructure should offer significant advantages such as availability, reliability, 
scalability and efficiency for these purposes, compared with existing systems. 
 
2. Background to VOTES 
The Virtual Organisations for Trials and Epidemiological Studies (VOTES) project has been 
funded by the MRC for three years to establish a re-usable Grid framework which will support three 
key stages of any clinical trial or observational study: (1) recruitment of potentially eligible 
participants, (2) data collection, and (3) study management. The framework itself will be comprised of 
specifically engineered collections of adaptable Grid services whose usage and combinations will 
depend upon the needs of the particular clinical study to support different flavours of CVO. 
Diagrammatically, the intention of VOTES is depicted in Figure 1 where the framework is used to 
generate a multitude of different CVOs allowing user-oriented, ethical access to and usage of clinical 
data sets. 
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Figure 1:  Clinical Virtual Organisations for Clinical Trials and Observational Studies 
 
The TransferGrid identified in Figure 1 will offer generic Grid services for security, data access 
and management, and data movement between repositories (Peers) hosted at the partner and 
collaborating institutions. The TransferGrid is to be hosted by the collaborating institutions, hence 
complete control over the technologies used and its’ design and architecture is possible. This core Grid 
infrastructure will then be expanded and refined to develop CVOs that include External Peers of two 
general classes: (a) Routine Repositories (such as those held by general practices, hospitals, disease-
specific registries, device registries, or the Office for National Statistics), and (b) Study Repositories 
(research systems developed for a particular trial or observational study).  External Peers will apply 
their own security policy, and may be intermittently connected to the TransferGrid.  Interfacing with 
routine repositories will be a highly involved and potentially politically sensitive process, requiring 
specific project resource. We outline initial experiences in dealing with access to such resources in 
Scotland section 3. 
Critical to the development of such a framework are languages and tools for implementing the 
rules and regulations (policies) relevant to clinical trials. A typical clinical trial or observational study 
will contain policies defining collections of entities and the relationships between them including: 
• roles – e.g. clinician, administrator, participant, pharmacist, steering committee member, data 
monitoring committee member, software/Grid engineer, and systems/database administrator;  
• level – e.g. central, regional, or national coordinating centre, and local clinical centre; 
• computational resources from supercomputers, farms, PCs, laptops, mobile devices; 
• specific software infrastructures to be used in the trial (such as analysis software), as well as 
specific Grid services (such as data access, integration, annotation, movement and replication 
services, Grid security authentication and authorisation services, and Grid workflows); 
• data resources such as clinical databases, disease-specific registries, and study-specific 
databases, as well as the data sets contained therein. 
Policies will specify and qualify permitted relationships between these entities, often at a fine 
granularity, and will provide the basis for establishing a given CVO (and hence for configuring the 
associated Grid infrastructure). One way that this can be supported is through XML sub-schemas for 
standard subsections of policies frequently used in CVOs, referencing existing standards where they are 
emerging for particular classes of entity.  In turn, these sub-schemas will be referenced by XML 
Schemas to create “Policy Templates”. A given policy instance (for a particular CVO) will then be 
constructed from a Policy Template with specifics for a required action and the associated security 
considerations. The final implementation will require both informal testing and documented validation 
against the policy set out in the user requirement specifications for that CVO Framework.  
Usage of the infrastructure developed through such policies will require that all policies are strictly 
adhered to. An example policy that a CVO framework would be expected to support would be:  for a 
specific trial, a study clinician working at the national coordinating centre, is allowed to see all trial 
data (except treatment allocation) for all participants in that country, but only summary data (e.g. a 
recruitment graph) for participants in other countries. A query not fulfilling all the terms or 
agreements defined by the CVO policy will be rejected at a given resource and the information 
associated with the query (the sender, nature of the request, etc) will be logged to enable this to be 
followed up, including a review of the implementation of the policy itself.   
To support usability concerns, a VOTES portal is under development using the GridSphere portal 
technology (www.gridsphere.org) which will host the CVOs associated with particular trials. Users 
accessing this portal will have a predefined role for the specific trials they are involved in. This 
information will be used to personalise their environment when using the portal, limiting the data sets 
they may see, and the services they can invoke. Ensuring the security of the location where these 
policies are hosted is therefore essential.  
Each CVO resource (e.g. Peer on the TransferGrid, trial database or clinical repository) will have 
its own local policies, capturing information about who may run queries against them, and what type of 
queries or data sets can be extracted from them.  For some external resources (i.e. resources not on the 
TransferGrid), such information might be implicit (e.g. only a GP is allowed to submit a query against 
their database), and local policy-based access control software might not exist.  In such cases, it is 
necessary to work with the controller of the external resource to define and subsequently enforce 
policies for querying the associated data sets (either directly or via access to adaptors or local services).  
For other resources (particularly the core TransferGrid), it will be possible to deploy the Grid 
infrastructure and thereby use local policies to control access to and usage of resources. 
Usage of Grid services often requires appropriate adaptors to facilitate access to, and usage of, 
specific data resources.  Such Grid middleware should provide facilities to access and use a variety of 
database technologies, matching the heterogeneity of resources in clinical trials.  The OGSA-DAI 
(www.ogsadai.org.uk) project provides mechanisms for managing, accessing and integrating XML 
relational and file data held in a variety of different databases (DB2, Oracle, MySQL, Xindice, etc) via 
the Grid.  The OGSA-DAI technology is currently being used to support access to, and storage of, the 
clinical data, as well as the extensive structured metadata needed to organise data associated with 
clinical repositories.  These metadata will typically describe how, when and by whom the data were 
produced, and will also describe the data structure and other salient features. The precise description of 
meta-data will facilitate the ability to conveniently find, create, store, access, integrate and 
subsequently analyse data from heterogeneous sources. 
 
3. Background to Scottish Data Sets, Services and Infrastructure 
One of the immediate key challenges that must be addressed in developing this framework is 
gaining access to appropriate data sets. Key sources of data in Scotland include national census data 
sets such as the General Register Office for Scotland (http://www.gro-scotland.gov.uk/) which includes 
information such as the registration of births, marriages, deaths as well as being the main sources of 
family history records. The access to such information whilst useful does not include direct health 
related information which will likely impact upon the suitability of patients to a trial. Primary care and 
secondary health care data sets are other immediate choices, however access to and usage of these data 
sets requires ethical approval. This is arguably the greatest hurdle that has to be overcome to realize the 
e-Health vision and allow clinical research to be supported. This should not be orthogonal to patient 
care however. Rather patients should have the opportunity to consent that their data can be accessed 
and used. In running a clinical trial, it is often the case that statistical information is enough. Thus 
rather than disclosing information on specific patients, statistical information is sufficient. Even here 
however, questions on ethics are raised. At the very least, doctors and their patients need to be included 
in any data access and usage decisions.  
The focal point of the primary and secondary care data sets being considered thus far within 
VOTES are based upon discussions with the NHS Information Services (www.isdscotland.org) and 
their associated technology providers. These include: 
• The General Practice Administration System for Scotland (GPASS) (www.gpass.co.uk) which 
is the core IT application used by over 85% of clinicians and general practitioners involved in 
primary care across Scotland. GPASS is the focus of primary care data sets being considered 
within VOTES. The VOTES team at NeSC Glasgow have been given a copy of the GPASS 
software and various training data sets. 
• Scottish Morbidity Records (SMR) (http://www.show.scot.nhs.uk/indicators/SMR/Main.htm)   
which includes good quality (linked) records relating to a variety of patient information 
records including: patient records discharged from hospital between January 1981 - March 
1997 (SMR1); COPPISH discharges from April 1997 onwards (SMR01); historic  discharges 
1981 – March 1997 (SMR4); COPPISH Admissions April 1996 onwards (SMR04); GRO 
Death Records  January 1980 - December1995; GRO Death Records  January 1996 onwards; 
SOCRATES (Cancer Registrations) 1980 onwards.  The VOTES team have currently been 
given access to the schema descriptions associated with these data sets. It is planned that an 
anonymised version of the datasets themselves will also be made available in the near future to 
the NeSC team. 
• Scottish Care Information (SCI) Store (http://www.show.scot.nhs.uk/sci/products/store) a 
batch storage system which allows hospitals to add a variety of information to be shared 
across the community, e.g. pathology, radiology, biochemistry lab results are just some of the 
data that are supported by SCI Store. Regular updates to SCI Store are provided by the 
commercial supplier using a web services interface. Currently there are 15 different SCI 
Stores across Scotland (with 3 across the Strathclyde region alone). Each of these SCI Store 
versions has their own data models (and schemas) based upon the regional hospital systems 
they are supporting. The schemas and software itself are still undergoing development. The 
VOTES team at NeSC Glasgow have been given a copy of the SCI Store software and various 
training data sets. 
It is the case that these solutions are currently undergoing a process of evolution across the NHS in 
Scotland. Commercial suppliers are producing software under contract by the NHS, yet it is currently 
the case that a fabric or overall systems architecture which will be used to integrate all of these 
software families and their associated data sets has not been fully defined. Thus for example, different 
sources of data and services use different classification schemes such as International Classification of 
Disease version 10 (ICD-10) and ICD version 9, as well as older Read coding exists. Similarly, systems 
such as the SCI Store laboratory systems often use different patient identifiers, hence SCI Store 
supports locally controlled cross-matching to ensure an incoming piece of information is attached to the 
correct patient’s record. This cross-matching is in turn based on a link to one or more local patient 
administration systems and the national Community Health Index (CHI) number patient identifier, 
equivalent to England’s National Health Service (NHS) number.  
There are different ways of getting access to the information held in SCI Store, e.g. through a 
secure web browser, through a fixed set basic web services, or through direct access to the back end 
database (based on SQL Server). It is this latter option which is most apposite to Grid based solutions 
and is being explored in VOTES since we broad range of access and usage capabilities. Thus it is not 
known exactly what information might be required for a clinical trial, or what web service interfaces 
should be supported. 
 For the end users, the emphasis of repositories such as SCI Store has been on the providing ‘look-
up’ access, e.g. to access laboratory test results. Ideally this information should be provided to 
clinicians so they are able to see results within minutes of them being analysed, as this reduces the 
requirement for telephone calls. Look-up access will always have its place, however looking up 
information in a remote repository has its limitations for example clinical information may not be 
integrated with the primary care record on a given GP’s system. With regard to VOTES, there might be 
numerous ways that the remote repository data might be integrated with the GPs data however what is 
clear is that this data should be ethical and electronically verifiable. For example so that the data has 
the appropriate type and is within given predictable constraints, e.g. upper and lower limits for a 
cholesterol level, or for a blood pressure measurement, or for a patients body mass index level etc. The 
term ethical is italicised here since it is essential to ensure that software solutions are developed for the 
right reasons and that ethical control of software IT push is ensured and that clinical researchers 
requirements are tempered by patient care necessity. Thus for example, software solutions which allow 
laboratory test results to be automatically incorporated into the primary care record without the GP’s 
knowledge could be envisaged. Such an approach could be considered to be of use however this would 
be potentially very dangerous and clinically unacceptable since the potential possibility for errors 
always exists. Hence, interfaces and associated causalities are needed which can facilitate user/clinician 
driven control which is in the best interest of the patient at all times. 
It goes without saying that the success of e-Health infrastructures across Scotland is by no means a 
technology-only challenge. The  hence Electronic Clinical Communication Implementation (ECCI) 
(http://www.show.scot.nhs.uk/ecci/) is targeted at funding local, people-focused implementation 
support as well as development of common standards such as access control protocols and information 
standards. 
 
4. Integrated Health Records within VOTES 
As CVOs necessarily span heterogeneous domains, a pre-requisite to the construction of 
distributed queries and aggregation or joining of returned data is the development and use of a standard 
method of classification or common vocabulary more generally. The VOTES team are currently 
exploring the various data classification schemes and associated data models used across Scotland. 
Currently the primary focus of VOTES is in understanding the schemas and associated classifications 
of the GPASS, SMR and SCI Store data sets. Once robust and validated solutions have been engineered 
for the VOTES TransferGrid for access to GPASS, SCI Store and the SMR data sets, these will be 
explored in the wider context of a peer grid. A key element in the realisation of the live system is trust: 
trust of the technology and trust of the people and process. To support this it is planned that the NeSC 
Glasgow researchers will be given honorary contracts to work at the NHS in Glasgow. Through 
immersing themselves in the NHS environment, a better understanding of the daily processes for data 
production, data management and general software IT support will be garnered. It is clear that to have 
any chance of wide scale uptake, the Grid cannot subsume existing infrastructures and practices. 
Instead, the Grid and associated solutions must be constrained to function within the context of existing 
solutions and practices.  
One key challenge in this is in understanding the currently used classifications and schemes and 
models that will have some future longevity. There currently exist a broad range of different standards 
and data classifications across the e-Health domain including efforts such as Health-Level 7 (HL7) 
(http://www.hl7.org/), SNOMED-CT (http://www.snomed.org/snomedct/), OpenEHR 
(http://www.openehr.org/), International Classification of Disease version 10 (ICD-10) and version 9 
(ICD-9) (http://www.connectingforhealth.nhs.uk/clinicalcoding/classifications/icd_10) and Read 
coding (http://www.connectingforhealth.nhs.uk/clinicalcoding/faqs/) classifications are used across the 
NHS along with many other standards for imaging such as DICOM (http://medical.nema.org/). It is 
possible to develop Grid based solutions which will allow access to and usage of data sets existing in or 
supporting all of these classifications, however the effort required to do so is considerable since they 
are often much more than simply a data classification. The HL7 data model and information schema for 
example incorporates messaging infrastructure and in its entirety appears to be (for the VOTES Grid 
team learning about the e-Health/clinical arena) a particularly complex solution which offers much 
functionality, but at, it would seem, the cost of complexity. It is also not clear precisely how widely 
supported the HL7 standards are in the NHS across Scotland. Instead the focus of VOTES currently is 
looking at those data sets associated with SMR, GPASS and SCI Store. 
Understanding the data models (schemas) of the data sets and software solutions that have been 
provided initially by the NHS and associated partners in VOTES is also a non-trivial process. In early 
explorations of the SCI Store database, data was provided and software however there was no explicit 
data model that was given. Of the ~100 tables that were provided, only ~15 of these contained training 
data sets. Extracting further information on these data models, e.g. the data schema was not 
immediately successful due to the commercial software providers asking for consultancy fees. Instead 
the VOTES team established the overall SCI Store data schema themselves. 
Information stored in clinical trials is by its nature, highly sensitive – drug treatments, conditions 
and diseases that patients have must be kept in the strictest confidence and the exact details should only 
be known about by a few privileged roles in the trial. This is one of the most fundamental challenges in 
this work – to realise the opportunities and benefits that can be brought to this field by Grid technology 
but to also maintain the high security standards that must be strictly adhered to. Within the Grid 
community VO security issues are generally grouped into the categories of: authentication – the 
discovery of a user’s identity, e.g. via Public Key Infrastructure (PKI) technology; authorization – the 
discovery of that user’s privileges based on their identity; accounting – logging the activity of users so 
that they can be held accountable for their actions within a system. Authentication is a well understood 
process in the Grid community however there are a variety of ways in which authorisation and 
accounting can be done. The NeSC at Glasgow have extensive experience of authorisation technologies 
and their application which are helping to guide the security solutions being put forward for the 
VOTES Grid framework. It would appear that there is no uniform security infrastructure in existence 
across the NHS. Instead various home grown solutions are the norm. Thus how firewalls are configured 
or how anonymisation is done and/or data encrypted is currently largely non-uniform. 
The definition of policies for security and their enforcement is currently being explored in initial 
prototypes of VOTES. One challenge is this area is that the clinical data sets we are dealing with are 
not always likely to be linked. Developing data Grids where single queries can be federated across 
multiple remote repositories and the results joined, requires that a common term is used for the 
subsequent join. Ideally all data should have for example the CHI number associated with it. At present 
this is not the case and different regions have supported this more than others, e.g. the CHI number is 
well advanced across Tayside, but less so across the other Scottish regions. Instead, record linkage is 
largely a process done internally by the NHS by institutions such as Information Services division of 
the NHS (www.isdscotland.org) however it should ideally be the case that other non-NHS bodies 
should be allowed to link data sets together. Thus it might well be the case that a clinical trial might 
want to link a multitude of NHS data sets such as SCI Store, with GPASS with disease registry data 
sets or other social classification data sets. Relying on internal NHS bodies to perform such work is not 
always practical, since they are primarily there to support IT facilities for patient care and not to 
support the academically oriented clinical research community. 
A further challenge in developing a reusable security infrastructure is that a common security 
model for the NHS does not yet exist. Thus each site, hospital, registry, trust will likely have their’ own 
in-house ways of setting up and enforcing security. It is unrealistic (it will be impossible) to try to 
enforce a new security model upon them, e.g. one based on advanced authorisation via Grid 
technologies. Until detailed evaluations by independent security focused IT staff from the NHS have 
worked with these technologies and are satisfied that they meet their stringent security requirements 
then these technologies will remain research prototypes only. Through VOTES, we are pushing these 
issues forward however and attempting to explore how we might define policies which can 
subsequently be enforced in restricting access to certain data sets by certain privileged personnel. 
In addition to authentication and authorization, another artefact of security that is essential in this 
domain is that of “anonymisation”. This process involves allowing less-privileged users to gather 
statistical data for the purposes of studies or trials, but without revealing the associated identifying data 
– this only being available to users with greater privileges. The NHS in Scotland currently achieves this 
by encrypting the unique CHI number associated with all patients. Once an anonymised patient has 
been matched for a clinical trial, this encrypted value can in principle be sent to the Practitioners 
Service group (http://www.psd.scot.nhs.uk/) of the NHS who will as one of the many services that they 
provide, decrypt it and contact the patients directly (assuming ethical permission has been granted for 
so doing) to ask if they wish to join the clinical trial. Several challenges must be overcome to support 
this including ensuring that only privileged users are able access and use data sets including this 
encrypted CHI number. A further challenge is that there are currently many independent solutions 
across the NHS for how they manage their infrastructures. Thus for example, there is no standardised 
way in which encryption is undertaken. Hence it is often difficult or impossible to ask PSD to de-
anonymise an encrypted CHI number if it is generated by arbitrary NHS trusts. Pragmatic solutions 
overcoming the nuances of NHS systems are thus necessary. 
Throughout the VOTES project, continuous ethical and legal overview of the solutions being put 
forward and the data sets being accessed are being made. This includes the perceived benefits of the 
research for the public, and is undertaken by independent ethical oversight committees. To support this, 
superior security roles for oversight committee members which allow access to all data sets and reports 
for given clinical trials will be made available. 
Many of the data access and security challenges depend upon the notion of consent. If a patient is 
willing that their data sets can be made available for research purposes then this greatly simplifies the 
ethical considerations which constrain the design space of the Grid framework. Within initial 
implementations in VOTES we have explored a variety of patient consent models. 
 
5. Initial VOTES Scenarios, Architecture and Implementation 
In designing a reusable Grid framework for clinical trials immediate restrictions are imposed on 
the possible architectural solutions. Thus it is unlikely that direct access to and usage of “live” NHS 
data sets and resources will be achieved, where direct here implies that the Grid infrastructure can issue 
queries to a remote NHS controlled resource containing un-anonymised patient information, i.e. to a 
resources behind the NHS firewall. Nevertheless, it is possible to design solutions capturing sufficient 
information needed for a clinical trial without over-riding existing security solutions or assuming 
ethical permissions where none have been granted. Possible solutions being explored here include a 
push model (where anonymised NHS data sets are exported) to the academic Grid community (or to an 
NHS server in a demilitarised zone of the NHS). Another model is to allow the GPs and clinicians to 
drive the recruitment process, provided they consider that this is in the best interests of the patients. 
The Grid framework is currently under production and is using a variety of Grid middleware. The 
basic architecture which supports federated queries in a user oriented but secure manner is depicted in 
Figure 2.  This infrastructure corresponds to one node of the Transfer Grid outlined above and is hosted 
on a trial test bed at the NeSC at the University of Glasgow. 
 
 
OGSA-DAI
Service
Globus
Container
Portal Grid Server Data Server
Driving
DB
SCI Store 2
(SQL Server)
SCI Store 1
(SQL Server)
Consent DB
(Oracle 10g)
RCB Test 
Trials DB
(SQL Server)
User 
Authentication Glasgow Other 
Transfer 
Grid 
Nodes
Remote 
Trust 
Policies
Authorisation     
Access Matrix 
Security Policies
Access 
Security 
Policies
Local 
Trust
Policies
Local 
Trust
Policies
Local 
Trust
Policies
 
Figure 2: NeSC Transfer Grid Node Architecture 
 
A GridSphere portal front-end communicates to a Globus Toolkit v4.0 (www.globus.org/toolkit) 
grid service, which in turn provides access to an OGSA-DAI data service. This runs queries from a 
“driving database” using standard SOAP message-passing, but also in turn runs queries from the 
subsidiary databases available from the pool for which it is responsible, using direct JDBC connections.  
The user accesses this infrastructure through the portal, and provided they have the appropriate 
privileges, they can bring back a range of data from the various remote databases appropriate to their 
role. Currently the test infrastructure at NeSC Glasgow consists of multiple SCI Store repositories, a 
GPASS repository, a clinical trial data base containing representative clinical trial data from the 
Robertson Centre for Biostatistics at the University of Glasgow, and a consent database. To show a 
proof of concept, we have established canned queries that allow unprivileged users to retrieve limited 
data-sets, with the identifying patient data anonymised and other restrictions applied, whilst other 
privileged users are able to access and see a richer set of non-anonymised data as shown in Figure 3. 
Through the use of this application, the end user is able to seamlessly access a set of resources, 
pertinent to clinical trials, in a dynamic, secure and pervasive fashion. Depending on the user’s 
privileges, the results returned have varying degrees of verbosity thereby allowing limited statistical 
analysis without compromising the privacy restrictions necessarily applied in such sensitive data. 
In the current version of the system to explore the problem space and gain familiarity with the 
clinical data sets used across Scotland, several canned clinical trial queries are supported which 
seamlessly access and use distributed back-end test databases as shown in Figure 3. 
 
 Figure 3: Screenshot of VOTES portal and privileged users result returned  
 
Currently the prototype system supports a variety of models which are allowing exploration of the 
potential solution space for patient consent across Scotland. For example solutions have been 
prototyped which allow patients to consent to their data being used for: 
• a specific clinical trial,  
• for a particular disease area  
• consent for their data being used generally.  
In addition, the system also allows for patients to opt out, i.e. their data sets may not be used for 
any purposes. Numerous variations on this are also being explored, e.g. the patients’ data may only be 
used provided they are contacted in advance. To support this, a consent database has been established 
and is used when joining of the federated queries is undertaken to decide whether the data should be 
displayed, displayed but anonymised, or not displayed at all.  
In the current implementation, data federation security is achieved at both local and remote level. 
The local level security, managed by each test site, filters and validates requests based on local policies 
at DBMS levels. The remote level security is achieved by the exchange of access tokens between the 
designated Source of Authority (SOA) of each site. These access tokens are used to establish remote 
database connections between the sites in the federation. In principle local sites authorise their users 
based on delegated remote policies.  
 
6. Conclusions and Future work 
The Grid is not a panacea for data access and integration and security, but helps to bring the issues 
on data access, integration and security to the fore. As such, the VOTES prototype software is very 
much a work in progress. Yet the experiences in developing this prototype are helping to gain a better 
understanding of the clinical domain problem space and shaping the planned Grid framework. The 
vision of a Grid framework eventually supporting a myriad of clinical trials and epidemiological 
studies is a compelling one, but can only be achieved once experiences have been gained in accessing 
and using a wide variety of clinical data sets. 
In developing the current prototype, it is apparent that there are a number of political and ethical 
issues that must be addressed when dealing with data-sharing between domains and these are inherently 
more difficult to deal with than the technological challenges. Whilst the NHS in Scotland and the UK 
more widely are taking steps to standardise the data-sets that they have, these are still far from being 
fully implemented (and accepted) by clinical practitioners. For instance, the CHI number has only been 
implemented across some regions of Scotland and therefore leaves certain areas with incomplete 
references. Those records that do not have the CHI number are referenced using a different Patient 
Identification (PID) number that will be idiosyncratic to the region in question. The Information 
Services group of the NHS in Scotland are working on record linkage and providing CHI numbers 
where the patient identification information can be confidently ascertained based on combinations of 
information such as names, addresses and dates of birth.  
There is also a need to build up a trust relationship with the end-user institutions that we are 
working with to provide this clinical infrastructure. This necessarily takes time and will be furthered by 
engaging in an exchange program where employees from NeSC work with and understand the 
processes in the NHS IT departments and vice-versa. 
The current Grid infrastructure described here has allowed the investigation of automatically 
implementing combinations of patient consent policies. Ideally such a consent register would be 
maintained nationally, however this does not exist yet but is planned with the electronic patient record 
under discussions across the NHS in Scotland. Demonstrations of working solutions showing the trade-
offs in consent or assent with opt in versus opt out possibilities allows the policy makers to see first 
hand what the impact of their ultimate decisions might have. We believe that it is easier to convince 
policy makers when they see actual working solutions rather than theoretical discussions of what might 
be achieved once the infrastructures are in place. 
The applications in this project are being developed with a view to being rolled out to the NHS 
Scotland in the first instance, moving from test data to “live” data with fully audited and standards-
compliant security, upon establishment of reliability and production value. The eventual vision is that 
this infrastructure will one day be available on a global scale allowing health information to be 
exchanged across heterogeneous domains in a seamless, robust and secure manner. In this regard, we 
are currently exploring international collaborative possibilities with the caBIG project in the US 
(https://cabig.nci.nih.gov/) and closer to home in genetics and healthcare projects across Scotland 
(http://www.innogen.ac.uk/Research/The-Scottish-Family-Health-Study).   
